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ABSTRACT
The methods based on the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas)
system have quickly gained popularity for genome editing and transcriptional regulation in many organisms, including
yeast. This review aims to provide a comprehensive overview of CRISPR application for different yeast species: from basic
principles and genetic design to applications.
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INTRODUCTION
In 2003, Francisco Mojica and colleagues discovered that the
spacer sequences from bacterial clustered regularly interspaced
short palindromic repeats (CRISPR) locimatch viral and conjuga-
tive plasmid sequences and hypothesized that CRISPR must be
part of the bacterial immune system (Mojica et al. 2005; Lan-
der 2016). In the following years, multiple studies had been
performed to unravel the mechanism of CRISPR functionality
(Lander 2016) until, in 2012, two research groups managed to
reprogram the targeting of CRISPR-associated nuclease (Cas9),
so Cas9 would introduce double-strand DNA breaks (DSBs) in
a sequence-specific manner in vitro (Gasiunas et al. 2012; Jinek
et al. 2012). Following this, applications of CRISPR/Cas9 for in
vivo genome editing in mammalian cells were published early
in 2013 (Cong et al. 2013; Mali et al. 2013), followed by DiCarlo
et al. (2013) reporting the usage of the system in the yeast Sac-
charomyces cerevisiae. Since then the technology has been opti-
mized and adapted for numerous organisms, covering applica-
tions from industrial biotechnology (van Erp et al. 2015) to plant
breeding (Bortesi and Fischer 2015) and treatment of human dis-
eases (Cai et al. 2016).
In native type II CRISPR/Cas systems, Cas9 is guided to the
target DNA region by a two-RNA molecule hybrid consisting of
CRISPR RNA (crRNA) and transactivating crRNA (tracrRNA). To-
gether with the tracrRNA, crRNA forms a secondary structure
loop, which recruits Cas9. The crRNA guides the system to a
genomic target of ∼20 bp through base pairing with the com-
plementary DNA strand. The particular genomic target must be
followed by the protospacer adjacentmotif (PAM) NGG. The Cas9
nuclease domain HNH then cleaves the DNA-strand comple-
mentary to the crRNA-guide sequence, while RuvC-like domain
cleaves the other DNA strand, thus resulting in a DSB. The DNA
cleavage is performed three nucleotides upstream of the PAM
site (Gasiunas et al. 2012). For easier use in genome editing, the
crRNA and tracrRNA can be fused tail to head via a linker into a
single guiding RNA (gRNA) (Jinek et al. 2012).
This review covers the technical details of the imple-
mentation of CRISPR/Cas-mediated genome editing in various
yeast species, transcriptional regulation via the enzymatically
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inactive ‘dead’ dCas9, which binds but does not cut the DNA
target (Jinek et al. 2012), and presents examples of applying the
technology for engineering of yeast cell factories.
CRISPR/Cas9 GENOME EDITING IN YEASTS
When Cas9 protein and gRNA are expressed in yeast cells, Cas9
introduces DSBs that must be repaired by the cells via non-
homologous end joining (NHEJ) or homologous recombination
(HR) (Liu et al. 2017). By supplying a DNA repair template for use
in HR, various DNA modifications can be obtained. In the case
of efficient cutting, the generated DSBs serve as a negative se-
lection. Thus, there is no need for using a selective marker as
in non-CRISPR genome editing methods. Relatively precise and
flexible targeting and elimination of the need for positive selec-
tion are the two key advantages of the CRISPR/Cas9 technology
for yeast genome engineering. Themethod also allows engineer-
ing of diploid and polyploid industrial strains (Ryan et al. 2014;
Zhang et al. 2014; Stovicek, Borodina and Forster 2015), which
are challenging to manipulate genetically due to the difficulties
with modifying multiple alleles and due to the lack of selec-
tion markers (Le Borgne 2012). Additionally, by combining sev-
eral gRNAs, multiple sites can be targeted simultaneously allow-
ing the unprecedented speed ofmultiple genetic edits (Ryan et al.
2014; Bao et al. 2015; Jakocˇiu¯nas et al. 2015a). On the downside of
CRISPR/Cas9, there is a considerable variation in efficiencywhen
targeting different loci, perhaps due to a positional effect of the
target region (Smith et al. 2016). At themoment, there also seems
to be an upper limit for the number of edits (up to six) that can be
introduced simultaneously as every additional introduced DSB
decreases the overall yield of surviving clones (Mans et al. 2015;
Jakocˇiu¯nas et al. 2015a). Furthermore, CRISPR/Cas9 multiplexing
still represents a significant increase in workload for finding cor-
rect clones.
Progress has been made on adapting the type II CRISPR/Cas
system, described in Streptococcus pyogenes (Chylinski et al. 2014),
to various yeast species—Saccharomyces cerevisiae (Jakocˇiu¯nas,
Jensen and Keasling 2016), Yarrowia lipolytica (Schwartz et al.
2016a), Komagataella phaffii (formerly Pichia pastoris) (Weninger
et al. 2016), Kluyveromyces lactis (Horwitz et al. 2015), Schizosac-
charomyces pombe (Jacobs et al. 2014), and the pathogenic yeast
species Candida albicans (Vyas, Barrasa and Fink 2015) and Cryp-
tococcus neoformans (Wang et al. 2016). We first discuss the de-
sign of the targeting gRNA sequence as a critical aspect of all
CRISPR/Cas9 applications. As the vastmajority of the studies de-
scribing CRISPR/Cas9 genome editing in yeasts have focused on
S. cerevisiae, the larger section dedicated to this model organism
also details some of the more general issues related to the Cas9-
mediated genome engineering. For clarity, the studies focusing
on the other yeasts are discussed in a separate section.
COMPUTATIONAL TOOLS FOR gRNA DESIGN
IN YEAST
Any ∼20-bp sequence proximal to the PAM site in the genome
can serve as the gRNA targeting sequence. The rationale behind
careful gRNA selection is to minimize the risk of Cas9-mediated
cleavage at unwanted sites in the genome (off-target effects) and
maximize the cutting efficiency at the selected site (on-target
activity). Other factors may outweigh the best parameters and
put additional constraints on the design, e.g. position of a target
proximal to the beginning of the ORF for generating premature
STOP codons or requirement of a target location in promoter/5′
UTR region in case of gene repression/activation experiments
(Mohr et al. 2016). Several web-based tools have been devel-
oped to facilitate and automatize the design of gRNA targets
(Table 1). Such tools aim mainly at providing guide sequences
that minimize the likelihood of off-target effects, matching all
possible targets within the given parameters against the refer-
ence genome. Some tools provide a list of targets with speci-
fied number of mismatches within the entire target sequence or
the ‘seed’ sequence (8–12 bp adjacent to the PAM site) (CRISPy
(Ronda et al. 2014; Jakocˇiu¯nas et al. 2015a); CRISPRdirect (Naito
et al. 2015)), filter out sequences with potential off-target ef-
fects (Yeastriction, Mans et al. 2015) or introduce a specificity
score based on number of mismatches within the target se-
quence and rank the targets accordingly (CRISPR-ERA, Liu et al.
2015; Benchling, ATUM gRNA design). CHOPCHOP (Labun et al.
2016) or E-CRISP (Heigwer, Kerr and Boutros 2014) provides the
possibility for user-defined parameters of the off-target eval-
uation. Even though off-target effects are considered unlikely
in such a small genome as yeast (Ryan et al. 2014; Jakocˇiu¯nas
et al. 2015a), it is advisable to double check the design using
yet another tool to avoid introduction of any undesired modi-
fications. Although several potential requirements for gRNA de-
sign have been suggested to ensure efficient generation of DSB
at the target site, it is still not easy to establish a set of golden
rules that would guarantee a success until more experimental
data have been acquired. Some of the tools highlight simple
features that might influence gRNA efficiency, such as poly T
presence in the sequence, GC content (CRISPRdirect) (Naito et al.
2015), AT content or self-complementarity of a gRNA molecule
and provide a score based on these parameters (Yeastriction, E-
CRISP, CRISPR-ERA) (Heigwer, Kerr and Boutros 2014; Liu et al.
2015; Mans et al. 2015). Other tools such as Benchling have im-
plemented more sophisticated efficiency scores based on an ex-
perimental evaluation of a large set of mammalian gRNAs and
their sequence features (Doench et al. 2014, 2016; Xu et al. 2015).
In some cases, users can even choose from several different al-
gorithms of the on-target evaluation (CHOPCHOP, E-CRISP). A
few tools also include information on the presence of a specific
restriction site in the target sequence (CHOPCHOP, CRISPRdi-
rect, Yeastriction) that might facilitate downstream validation
of the cloned target molecule (Mans et al. 2015). CRISPR-ERA or
E-CRISP also facilitate designing of a gRNA molecule for engi-
neering applications other than genome editing, e.g. gene re-
pression or gene activation applications. While some of the
tools support only one yeast genome, typically Saccharomyces
cerevisiae reference genome, others provide gRNA design op-
tion for several yeast species or various strains of S. cerevisiae
(Table 1). The CRISPy tool web server implementation, CRISPy-
web (Blin et al. 2016), allows for user upload of any GenBank for-
mat genome. CRISPRdirect is being frequently updatedwith new
genomes, and CHOPCHOP offers an upload of new genomes on
request.
CRISPR/Cas9 AND GENOME EDITING IN
SACCHAROMYCES CEREVISIAE
Saccharomyces cerevisiae is an important eukaryotic model organ-
ism and also a widely used industrial host for production of fu-
els, chemicals and recombinant proteins (Borodina and Nielsen
2014; Li and Borodina 2015). Thanks to its excellent HR capabil-
ity, S. cerevisiae is relatively easy to engineer genetically. Below
we discuss the ways for delivering Cas9, gRNA and DNA repair
templates to S. cerevisiae (summarized in Table 2).
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Table 1. List of selected web-based bioinformatics tools for gRNA design in yeast.
Name Link Reference Input Main features Yeast species
CRISPy http://staff.biosu
stain.dtu.dk/laeb/
crispy yeast/
Ronda et al. (2014 );
Jakocˇiu¯nas et al.
(2015a)
Gene name/ID Off-target S. cerevisiae
reference, CEN.PK
CRISPy-web http://crispy.second
arymetabolites.org
Blin et al. (2016) Gene name/ID,
genomic coordinates
Off-target Any user-submitted
genome
CRISPR-ERA http://crispr-
era.stanford.edu/
Liu et al. (2015) Gene name,
genomic
coordinates,
sequence
Off-target, efficiency
score, gene repres-
sion/activation
S. cerevisiae
reference
CHOPCHOP v2 http://chopchop.cbu.
uib.no
Labun et al. (2016) Gene name,
genomic
coordinates,
sequence
Off-target user
defined, on-target
algorithm,
restriction sites
S. cerevisiae
reference,
C. albicans,
C. tropicalis,
C. glabrata,
P. pastoris
CRISPRdirect https://crispr.
dbcls.jp/
Naito et al. (2015) Gene name,
genomic
coordinates,
sequence
Off-target, GC
content, poly T,
restriction sites
S. cerevisiae,
Sch. pombe,
K. lactis,
Y. lipolytica,
C. albicans,
C. glabrata
E-CRISPR http://www.e-
crisp.org/
Heigwer, Kerr and
Boutros (2014)
Gene symbol,
sequence
Off-target, on-target
algorithm, gene
activa-
tion/repression
S. cerevisiae,
Sch. pombe
Yeastriction http://yeastriction.
tnw.tudelft.nl
Mans et al. (2015) Gene name Off-target, AT
content, self-
complementarity,
restriction sites
S. cerevisiae, several
strains
Benchling https://benchling.
com/ crispr
Gene name,
coordinates,
sequence
Off-target, on-target
algorithm
S. cerevisiae
reference,
Sch. pombe,
C. albicans,
Y. lipolytica
ATUM gRNA Design
Tool
https://www.atum.
bio/eCommerce/
cas9/input
Gene name,
coordinates,
sequence
Off-target S. cerevisiae
reference
Cas9 expression
The most commonly used Cas9 gene variant in S. cerevisiae has
been Cas9 from Streptococcus pyogenes, fused with a nucleolar lo-
calization sequence. The DNA sequence of Cas9 can be either
native (Ryan et al. 2014; Bao et al. 2015), human codon-optimized
(DiCarlo et al. 2013; Gao and Zhao 2014; Zhang et al. 2014; Laugh-
ery et al. 2015; Mans et al. 2015; Stovicek, Borodina and Forster
2015; Jakocˇiu¯nas et al. 2015a) or yeast codon-optimized (Horwitz
et al. 2015; Generoso et al. 2016) (Table 2). Only Xu et al. (2015)
reported the use of St. thermophilus CRISPR3 loci-encoded Cas9
(recognizing a different PAM site), albeit with much lower en-
gineering efficiency. The Cas9 gene was most commonly ex-
pressed under the control of constitutive promoters of differ-
ent strengths from self-replicating low-copy centromeric vec-
tors (DiCarlo et al. 2013; Zhang et al. 2014; Stovicek, Borodina and
Forster 2015; Jakocˇiu¯nas et al. 2015a) or high-copy 2μ vectors (Gao
and Zhao 2014; Ryan et al. 2014; Bao et al. 2015; Horwitz et al. 2015;
Laughery et al. 2015; Generoso et al. 2016) or integrated into the
genome (Mans et al. 2015) (Table 2). Expression of Cas9 on a high-
copy vector from a strong constitutive promoter led to a negative
influence on the growth of some yeast strains (Ryan et al. 2014;
Generoso et al. 2016). However, this problem was not observed
in other studies that used the same mode of Cas9 expression
(Gao and Zhao 2014; Bao et al. 2015; Laughery et al. 2015). The
toxicity of Cas9 nuclease could be avoided by using weaker pro-
moters for Cas9 expression (Ryan et al. 2014; Generoso et al.
2016). Overall, the form of Cas9 expression does not seem to be
a critical parameter in CRISPR/Cas9 engineering strategies for
S. cerevisiae.
Guide RNA expression
Design, expression and delivery of the gRNA components are
crucial parameters for successful CRISPR/Cas9 engineering. In
S. cerevisiae, the most common strategy has been to express a
chimeric gRNA molecule from a high-copy vector to ensure its
abundant expression (Table 2). Both ends of the gRNA molecule
must be precisely defined to create a functional Cas9/gRNA com-
plex. Functional gRNA transcription has been achieved using (i)
an RNA polymerase III (Pol III) promoter that provides a tran-
script with a leader sequence cleaved during molecule matu-
ration (DiCarlo et al. 2013; Farzadfard, Perli and Lu 2013); (ii)
Pol III promoters containing cis-regulatory elements within the
mature RNA molecule (tRNA) combined with a ribozyme, cleav-
ing the transcript on its 5´ end (Ryan et al. 2014); and (iii)
an RNA polymerase II (Pol II) promoter, if the gRNA molecule
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Table 2. List of available CRISPR/Cas9 tools for yeast.
Reference Availability
Organism and strain
(ploidy)
Cas9 expression
(vector, selection
marker, promoter)
gRNA expression
(vector, selection
marker, promoter,
terminator)
Application and
efficiency
S. cerevisiae genome editing
DiCarlo et al. (2013) Addgene S. cerevisiae BY4733
(n)
CEN/ARS, TRP1,
PTEF1/GALL-Cas9
2μ, URA3,
PSNR52/TSUP4
Single-gene
disruption/marker
cassette insertion:
99%
Gao and Zhao (2014) Addgene S. cerevisiae
LPY16936 (n)
2μ, LEU2, PADH1-Cas9 2μ, URA3, PADH1-HH
ribozyme/HDV
ribozyme-TADH1
Single-gene
disruption: 100%
Ryan et al. (2014) On request S. cerevisiae S288C (n,
2n) ATCC4124 (poly
n)
a2μ, kanMX,
PRNR2-Cas9b
tRNAPro -HDV
ribozyme/TSNR52
Single/multiple˙gene
disruption(s):
90%–100%/19%–85%,
three-part marker
cassette insertion:
70%–85%
Bao et al. (2015) Addgene S. cerevisiae BY4741
(n) CEN.PK2–1c (n)
a2μ, truncated URA3,
PTEF1-iCas9b
PSNR52-crRNA/TSUP4,
PRPR1-tracrRNA/TRPR1
Single/multiple-
gene disruption:
27%–100%
Zhang et al. (2014) Addgene S. cerevisiae ATCC
4124 (poly n)
CEN/ARS, natMX,
PTEF1-Cas9
2μ, hphMX,
PSNR52/TSUP4
Single-gene
disruption: 15%–60%
Jakocˇiu¯nas et al.
(2015a)
On request S. cerevisiae
CEN.PK2–1c (n)
CEN/ARS, TRP1,
PTEF1-Cas9
2μ, LEU2, PSNR52/TSUP4 Single/multiple-
gene disruption(s):
100%/50%–100%
Mans et al. (2015) Euroscarf S. cerevisiae
CEN.PK2–1c (n)
CEN.PK113–7D (n)
CEN.PK122 (2n)
integr. can1::PTEF1-
Cas9-natMX
2μ, URA3,
amdSYM/hphMX/
kanMX/LEU2/natMX/
HIS3/ TRP1,
PSNR52/TSUP4
Single-gene
deletion: 25%–75%,
multiple-gene
deletions/multiple-
gene cassette
insertions:
65%–100%
Stovicek, Borodina
and Forster (2015)
Addgene S. cerevisiae
CEN.PK113–7D (n)
Ethanol Red,
CEN/ARS, kanMX,
PTEF1/ADH1-Cas9
2μ, natMX,
PSNR52/TSUP4
Single-gene
disruption and gene
cassette insertion:
65%–97%CLIB382, CBS7960
(2n)
Horwitz et al. (2015) On request S. cerevisiae
CEN.PK2–1c (n)
integr. gre3::PFBA1-
Cas9c-hphMX
2μ,
URA3/HIS3/natMX,
PSNR52/TSUP4
Single allele swap:
82%–100%,
multiple-gene
disruptions:
65%–91%,
multiple-gene
cassette
integrations: 4.2%
Tsai et al. (2015) On request S. cerevisiae D452–2
(n)
CEN/ARS, natMX,
PTEF1-Cas9
2μ, hphMX,
PSNR52/TSUP4
Two part-gene
cassettes integration
into a single-gene
locus: 25%–100%
Laughery et al. (2015) Addgene S. cerevisiae BY4741
(n)
a2μ, LEU2/URA3,
PTDH3-Cas9
PSNR52/TSUP4 Single-gene
disruption: 97%–98%
Lee et al. (2015) Addgene S. cerevisiae S288C (n) aCEN/ARS, URA3,
PPGK1-Cas9
tRNAPhe-HDV
ribozyme/TSNR52
Single/multiple-
gene disruption(s):
96%/21%–76%
Jakocˇiu¯nas et al.
(2015b)
On request S. cerevisiae
CEN.PK111−27B (n)
CEN/ARS, TRP1,
PTEF1-Cas9
2μ, LEU2, PSNR52/TSUP4 Multiple part gene
cassette integrations
into multiple gene
loci: 30%–97%
Ronda et al. (2015) On request S. cerevisiae
CEN.PK2–1c (n)
CEN/ARS, TRP1,
PTEF2-Cas9
2μ, natMX,
PSNR52/TSUP4
Gene cassette
integration into
multiple intergenic
loci: 84–100%
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Table 2 (continued).
Reference Availability
Organism and strain
(ploidy)
Cas9 expression
(vector, selection
marker, promoter)
gRNA expression
(vector, selection
marker, promoter,
terminator)
Application and
efficiency
Shi et al. (2016) On request S. cerevisiae HZ848
(n), CEN.PK2–1c (n)
a2μ, truncated URA3,
PTEF1-Cas9
PSNR52-crRNA/TSUP4,
PRPR1-tracrRNA/TRPR1
Long gene fragment
integration into
multiple genomic
loci: 75%–88%
Generoso et al. (2016) Addgene S. cerevisiae
CEN.PK113–7D (n)
Ethanol Red (2n)
a2μ, kanMX/natMX,
PROX3-Cas9c
PSNR52/TSUP4 Single and
double-gene
disruptions:
91%–98%
Jessop-Fabre et al.
(2016)
Addgene S. cerevisiae
CEN.PK113–7D (n)
Ethanol Red (2n)
CEN/ARS, kanMX,
PTEF1-Cas9
2μ, natMX,
PSNR52/TSUP4
Integration of a long
gene fragment into a
single locus:
95%–100%/multiple
loci: 60–70%
Reider Apel et al.
(2016)
On request S. cerevisiae BY4742
(n)
a2μ, URA3, LEU2,
PADH1-Cas9c
tRNATyr -HDV
ribozyme/TSNR52
Three part-gene
cassette integration
into mutiple
intergenic loci:
40%–95%
Garst et al. (2017) On request S. cerevisiae a2μ, truncated URA3,
PTEF1-iCas9b
PSNR52-crRNA/TSUP4,
PRPR1-tracrRNA/TRPR1
Single-gene
non-sense mutation:
70%–95%
BY4709 (n)
RM11–1 (n)
Liu et al. (2017) On request S. cerevisiae var.
boulardii ATCC
MYA-796 (n)
CEN/ARS, natMX,
PTEF1-Cas9
2μ, hphMX,
PSNR52/TSUP4
Single/double-gene
disrup-
tion(s):100%/N/A
Nishida et al. (2016) Addgene S. cerevisiae CEN/ARS, LEU2,
PGAL1-nCas9
(840A)/nCas9
(D10A)/n(d)Cas9
(D10A/840A)-
PmCDA1
2μ, URA3,
PSNR52/TSUP4
Cytidine deaminase-
mediated
single/double-gene
disruption(s):
16%–54%/14%–31%BY4741 (n)
YPH501 (2n)
Vanegas, Lehka and
Mortensen (2017)
On request S. cerevisiae
S288C (n)
PJ69–4 (n)
Integr. intergenic
X-3::PTEF1-Cas9-URA3
CEN/ARS, LEU2
PSNR52/TSUP4
Integration of
three-part
multiple-gene
fragment into an
intergenic site: 100%
S. cerevisiae gene activation/repression
Gilbert et al. (2013) Addgene S. cerevisiae
W303
CEN/ARS, LEU2,
PTDH3-dCas9(-Mxi1)
CEN/ARS, URA3,
PSNR52/TSUP4
Several 10-fold
reporter gene
transcription
repression (CRISPRi)
Farzadfard, Perli and
Lu (2013)
Addgene S. cerevisiae
W303 (n)
integr. trp:: PTPGI-
dCas9c-VP64-TRP1
2μ, HIS3/LEU2,
PRPR1/TRPR1
Transcription
activation (activator
domain)/repression
(CRISPRi)
Zalatan et al. (2015) Addgene S. cerevisiae
W303 (n)
integr.
leu2/his3::PTDH3/GAL10-
dCas9-CgLEU2/HIS3
CEN/ARS, URA3,
PSNR52-gRNA-
sc(scaffold)RNA/TSUP4
Multiple-gene
transcription
activation
(RNA-binding
chimeric activa-
tors)/repression
(CRISPRi)
Chavez et al. (2015) Addgene S. cerevisiae
W303 (n)
CEN/ARS, TRP1,
PTDH3-dCas9-VPR
2μ, URA3,
PSNR52/TSUP4
Transcription
activation (multiple
activation domains)
Smith et al. (2016) Addgene S. cerevisiae
BY4741 (n)
aCEN/ARS,
TRP1/URA3,
PTEF1-dCas9-Mxi1
PRPR1 (TetO)/TRPR1 Transcription
repression
(repression domain-
CRISPRi)
6 FEMS Yeast Research, 2017, Vol. 17, No. 5
Table 2 (continued).
Reference Availability
Organism and strain
(ploidy)
Cas9 expression
(vector, selection
marker, promoter)
gRNA expression
(vector, selection
marker, promoter,
terminator)
Application and
efficiency
Vanegas, Lehka and
Mortensen (2017)
On request S. cerevisiae
S288C (n)
PJ69–4 (n)
Integr. Intergenic
X-3::PTEF1-
dCas9c/dCas9-VP64-
URA3
CEN/ARS, LEU2
PSNR52/TSUP4
Transcription
activation (activator
domain)/repression
(CRISPRi)
Deaner and Alper
(2017)
On request S. cerevisiae
BY4741 (n)
aCEN/ARS, LEU2,
PTDH3-dCas9-
Mxi1/PTDH3-dCas9-
VPR
PSNR52/TSUP4 Graded gene activa-
tion/repression (fold
transcription
activation-gene
silencing)
K. lactis
Horwitz et al. (2015) On request K. lactis ATCC8585 (n) integr. Klgal80::PFBA1-
Cas9c-hphMX
pKD1, natMX,
PSNR52/TSUP4
Multiple-gene
cassette insertion
into multiple-gene
loci: 2.1%
Y. lipolytica
Schwartz et al.
(2016a)
Addgene Y. lipolytica ATCC
MYA-2613 (n)
aCEN, LEU2,
PUAS1B8-TEF-Cas9c
SCR’-tRNAGly/polyT Single-gene
disruptions
(NHEJ/HR):
90%–100%/64%–88%
(100% in KU mutant)
Gao et al. (2016) Addgene Y. lipolytica ATCC
201 249 ATCC
MYA-2613 (n)
aCEN, LEU2/URA3,
PTEFin-Cas9
PTEFin-HH
ribozyme/HDV
ribozyme-TMIG1
Single-gene
disruption
(NHEJ/HR):
62%–98%/72% (94%
in KU mutant),
multiple-gene
disruptions (NHEJ):
19%–37%
Schwartz et al.
(2016b)
Addgene Y. lipolytica ATCC
MYA-2613 (n)
aCEN, LEU2,
PUAS1B8-TEF-Cas9c
SCR’-tRNAGly/polyT Gene cassette
integration into an
intergenic locus:
48%–69%
Ko. phaffii (P. pastoris)
Weninger et al.
(2016)
On request Ko. phaffii (P. pastoris)
CBS7435 (n)
PARS1a, ZEO,
PHTX1-Cas9
PHTX1-HH
ribozyme/HDV
ribozyme-TAOX1
Single-gene
disruption:
87%–94%,
double-gene
disruptions: 69%
Sch. pombe
Jacobs et al. (2014) Addgene Sch. pombe (n) aars, ura4, Padh1-Cas9 Prrk1/HH
ribozyme-Trrk1
Single-gene
disruption (allele
swap): 85%–90%
Fernandez and Berro
(2016)
On request Sch. pombe FY527 (n)
FY528 (n)
aars, ura4/fex1,
Padh1-Cas9
Prrk1/HH
ribozyme-Trrk1
Single-gene deletion
(ORF removal): 33%
C. albicans
Vyas, Barrasa and
Fink (2015)
On request C. albicans SC5314
(2n)
aintegr. ENO1 locus,
natMX, PENO1-Cas9c
PSNR52/TENO1 Single/multiple gene
disruption(s):
60%–80%/20%
Min et al. (2016) On request C. albicans SC5314
(2n) SN152 (2n)
linear cassette,
PENO1-Cas9c
linear cassette,
PSNR52/TENO1
Single-gene deletion
(ORF replacement
with marker
cassette): 45%–67%
C. glabrata
Enkler et al. (2016) On request C. glabrata CBS138
(n)
CEN, TRP1,
PCgCYC1-Cas9
CEN, LEU2,
PCgRNAH1/TCgTY2
Single-gene
disruption
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Table 2 (continued).
Reference Availability
Organism and strain
(ploidy)
Cas9 expression
(vector, selection
marker, promoter)
gRNA expression
(vector, selection
marker, promoter,
terminator)
Application and
efficiency
Cr. neoformans
Wang et al. (2016) On request Cr. neoformans
serotype D strain
JEC21 (n)
alinear vector, URA5,
PACT1-Cas9
URA5, PCnU6/polyT Single-gene
disruption
(NHEJ/HR):
40%–90%/20%–90%
Arras et al. (2016) On request Cr. neoformans
serotype A strain
H99 (n)
integr. ‘Safe
Heaven’-PTEF1-Cas9
linear vector,
PACT1-HH
ribozyme/HDV
ribozyme-TTRP1
Single-gene deletion
(ORF replacement
with marker
cassette): 65%–70%
The Cas9 gene is a human codon-optimized version unless otherwise marked. Addgene CRISPR/Cas9 plasmids for use in yeast are available at
https://www.addgene.org/crispr/yeast/. Euroscarf deposited vectors can be ordered here www.euroscarf.de.
HH—Hammerhead ribozyme, HDV—hepatitis delta virus ribozyme, iCas9 – mutated ‘hyperactive’ variant, nCas9 – mutated ‘nicking’ variant causing single-strand
DNA break, dCas9 – ‘dead’ nuclease activity-lacking variant, PmCDA1 – cytidine deaminase from sea lamprey (Petromyzon marinus), Mxi1 – mammalian transcriptional
repressor, VP64 – mammalian transcriptional activator domain, VPR—VP64-p65-Rta tripartite activator domain.
aBoth components on a single expression element.
bNative S. pyogenes Cas9.
cSpecies codon-optimized Cas9.
Figure 1. Overview of CRISPR/Cas9-mediated genome editing in yeast. (A) Illustration of Cas9 expression and various means of gRNA expression. (B) Mechanism of
Cas9/gRNA ribonucleoprotein complex action, NGG (PAM site) highlighted in orange letters. (C) Different donor DNA templates for DSB repair. Pol II/III—RNA Poly-
merase II/III, NLS—nucleolar localization sequence, cis—cis regulatory element (tRNA), L—self-cleaved leader sequence (SNR52), cr—crRNA, tracr—tracrRNA, HH—
hammerhead ribozyme, HDV—hepatitis delta virus ribozyme, ∗—STOP codon.
is flanked with two ribozymes executing cleavage on both
ends of the molecule (Gao and Zhao 2014) (Fig. 1). Besides
the chimeric gRNA approach, separate expression of a target-
ing crRNA array driven by a Pol III promoter, processed by na-
tive RNA processing enzymes, and tracrRNA transcribed from
another Pol III promoter has been reported (Bao et al. 2015).
The expression cassette containing SNR52 promoter and SUP4
terminator, an approach shown to produce prokaryotic tRNA
molecules in yeast (Wang and Wang 2008), was successfully
used for targeting a single gene in haploid or diploid labora-
tory strains with engineering efficiencies reaching 100% (Di-
Carlo et al. 2013; Horwitz et al. 2015; Laughery et al. 2015;
Mans et al. 2015; Jakocˇiu¯nas et al. 2015a; Generoso et al. 2016)
(Table 2). It is important to mention that engineering efficien-
cies discussed in this review are defined as the number of clones
with the desired genomic edit per number of clones surviving
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after the transformation. Such values should not be mistaken
with transformation efficiency values used traditionally in non-
CRISPR engineering studies as these relate to the number of
viable cells in the transformation reaction (Storici et al. 2003;
Alexander, Doering and Hittinger 2014). Although some stud-
ies also provide transformation efficiency values that reflect the
number of cells not surviving the transformation (DiCarlo et al.
2013; Stovicek, Borodina and Forster 2015), many others do not,
leaving the engineering efficiency as the only relevant bench-
mark. The SNR52 promoter/SUP4 terminator setup also allowed
for gene deletion in various diploid industrial strains with effi-
ciencies ranging between 65% and 78% (Stovicek, Borodina and
Forster 2015) and even polyploid strains with 15%–60% efficiency
(Zhang et al. 2014) (Table 2). The expression of a gRNA fused to
a Hepatitis delta virus (HDV) ribozyme controlled by a tRNA pro-
moter and SNR52 terminator led to almost 100% gene deletion
efficiency in a diploid laboratory strain and more than 90% in
a polyploid industrial strain (Ryan et al. 2014). As for the third
mentioned approach, a gRNA molecule flanked with Hammer-
head (HH) and HDV ribozymes on the 5′ and 3′ end, respectively,
expressed from ADH1 promoter also enabled efficient gene dis-
ruption in a laboratory strain (Gao and Zhao 2014). The crRNA
array method achieved efficiencies of 76%–100% in a laboratory
strain after several days of outgrowth of the transformed cells
(Bao et al. 2015).
When a researcher decides to engineer a targeted genomic
locus, only the ∼20 bp recognition sequence of a gRNAmolecule
needs to be modified to redirect the Cas9/gRNA complex to a
particular target site. Several ways of obtaining an expression
vector with a customized gRNA molecule have been described
(Fig. 2). Several studies exchanged the recognition sequence of a
gRNA vector using whole vector amplification with primers con-
taining a new target-specific 20-bp region. Vector circularization
was achieved via PCR with a phosphorylated primer, followed
by ligation (Stovicek, Borodina and Forster 2015; Jakocˇiu¯nas et al.
2015a), in vivo in yeast or in vitro Gibson assembly using two oli-
gos overlapping at the target sequence (Generoso et al. 2016), or
via restriction-free cloning (van den Ent and Lo¨we 2006) with two
60-bp complementary oligos containing a target sequence (Ryan
and Cate 2014). In other studies, two target-specific complemen-
tary oligos containing sequences overlappingwith the gRNA cas-
sette were cloned into a vector using Gibson assembly (Reider
Apel et al. 2016) or restriction sites located between promoter
and the gRNA structural part (Laughery et al. 2015; Lee et al. 2015),
or transformed directly into yeast along with the digested ex-
pression vector (Mans et al. 2015). Alternatively, the gRNA cas-
sette was amplified using two-step fusion PCR and cloned via
Gibson assembly (DiCarlo et al. 2013) and standard restriction
cloning (Chin et al. 2016) or transformed along with a digested
expression vector for in vivo vector gap repair in yeast (Horwitz
et al. 2015). To omit the PCR amplification step, customized gRNA
cassettes can be synthesized as gene blocks and integrated into
a vector via restriction cloning (Zhang et al. 2014) or USER as-
sembly (Ronda et al. 2015; Jakocˇiu¯nas et al. 2015b). Lastly, Golden
gate cloning of synthetic parts of the crRNA array has also been
shown (Bao et al. 2015).
In summary, researchers can choose from a number of
cloning systems for generation of a target gRNA molecule and
can also benefit from online tools facilitating the particular
cloning design (Laughery et al. 2015; Mans et al. 2015) or de-
tailed (Ryan, Poddar and Cate 2016) and straightforward pro-
tocols (Jakocˇiu¯nas et al. 2015a). However, even in its simplest
version, the CRISPR/Cas9 engineering relies on a gRNA vector
construction, which can be laborious and costly. The gap repair
approach developed by Horwitz et al. (2015) skips the cloning
step. However, it requires longer DSB repair templates, high ef-
ficiency of HR in the strain and may result in a non-equimolar
expression of the gRNAs when multiplexing. A lower efficiency
of engineering with vectors based on in vivo assembly has been
documented (Mans et al. 2015; Generoso et al. 2016).
One can also choose to express Cas9 and gRNA from a sin-
gle vector (Ryan et al. 2014; Bao et al. 2015; Laughery et al. 2015;
Generoso et al. 2016). However, due to the large size of the Cas9
gene, generation of a gRNA via the whole plasmid PCR amplifi-
cation (Ryan and Cate 2014) might be difficult. Such a system is
also not compatible with the gap repair gRNA generation as this
one requires expression of Cas9 prior the transformation with
the gRNA vector (Walter, Chandran and Horwitz 2016).
Multiplexing gRNA expression
In S. cerevisiae, efficient HR system allows creating multiple
genomic changes simultaneously using CRISPR/Cas9. For each
genome edit, an individual gRNA must be expressed and a
repair template delivered into the cells. The multiple gRNA
expression has been achieved using (i) several vectors with
different selection markers containing up to two different gRNA
expression cassettes (Mans et al. 2015), (ii) a single expression
vector carrying several gRNA cassettes (Ryan et al. 2014; Lee
et al. 2015; Jakocˇiu¯nas et al. 2015a), (iii) an array of different in-
terspaced crRNAs (Bao et al. 2015) or (iv) different linear gRNA
expression cassettes transformed alongwith a single gapped ex-
pression vector (Horwitz et al. 2015). When up to three differ-
ent vectors, each carrying two gRNA expression cassettes were
transformed, 100%, 70% and 65% efficiency of two, four or six
gene deletions was achieved, respectively (Mans et al. 2015). The
expression of five individual gRNAs from one vector provided
target efficiencies ranging between 50% and 100% (Jakocˇiu¯nas
et al. 2015a). Ryan et al. (2014) reported successful gene deletion
of two or three genes with efficiencies of 86% and 81% in haploid
and 43% and 19% in diploid strains using HDV-gRNA expression
cassettes in a single expression vector, respectively. Cloning of
crRNA arrays targeting three different genes achieved engineer-
ing efficiencies ranging between 27% and 100% (Bao et al. 2015).
The gap repair approach using the transformation of three dif-
ferent gRNA cassettes and a single open vector enabled recovery
of 64% positive three-gene deletion mutants (Horwitz et al. 2015)
(Table 2).
As described above, all setups enabled successful marker-
free multiplexed genome editing in S. cerevisiae. However, de-
spite the reported encouraging results, yeast strains can differ in
engineering efficiencies given rather by their nature than differ-
ences in the described procedures. Diploid or polyploid indus-
trial strains can be especially difficult to engineer (Zhang et al.
2014; Stovicek, Borodina and Forster 2015; Generoso et al. 2016),
andmultiplexing can createmorework on the other end to iden-
tify the correct clones. The CRISPR/Cas9 system also greatly fa-
cilitates the sequential introduction of multiple genomic edits.
For repeated rounds of editing, the strain is cultivated in the ab-
sence of selection pressure for gRNA vector, while maintaining
selection pressure for Cas9 vector. Then a new gRNA vector can
be introduced to accomplish the next round of genetic modifi-
cations. In the final strain, both vectors can be removed in the
absence of selection pressure to generate a strain free of selec-
tion markers (Stovicek, Borodina and Forster 2015; Jessop-Fabre
et al. 2016).
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Figure 2. Generation of specific gRNA expression cassettes. (A) Vector can be circularized via ligation (one oligo phosphorylated) (Jakocˇiu¯nas et al. 2015a; Stovicek,
Borodina and Forster 2015), ligation-free primer extension reaction (Tsai et al. 2015; Ryan, Poddar and Cate 2016), Gibson assembly or recombination in vivo (pair of
oligos overlapping at the specific gRNA target sequence) (Generoso et al. 2016). (B) Short synthetic oligos are cloned via e.g. Gibson assembly (oligos with overhangs
homologous to the ends of the digested vector) (Reider Apel et al. 2016), restriction cloning (oligos with overhangs complementary to a particular restriction site)
(Laughery et al. 2015), modular cloning (seamless assembly using type IIS restriction enzymes, oligos with overhangs complementary to a particular restriction site)
(Lee et al. 2015; Vyas, Barrasa and Fink 2015) or in vivo in yeast (Mans et al. 2015). (C) Cloning of the two-step PCR generated gRNA cassette via Gibson assembly (DiCarlo
et al. 2013) or restriction cloning (Chin et al. 2016). (D) Several single gRNA cassettes cloned via Gibson assembly (Weninger et al. 2016), restriction cloning (Ryan et al.
2014) or modular assembly (Lee et al. 2015). Alternatively, two-gRNA cassette fragments in opposite orientation can be amplified in one reaction and cloned (Mans et al.
2015; Generoso et al. 2016). (E) Pool of several single gRNA cassettes transformed to yeast cells with a gapped vector for in vivo recombination (Horwitz et al. 2015). (F)
crRNA array is cloned via Golden gate assembly of short synthetic fragments with homologous overlaps (Bao et al. 2015).
DNA repair templates
As mentioned above, the dominant mode of DSB repair in S.
cerevisiae is HR when a homologous donor template is avail-
able. NHEJ response in S. cerevisiae provides unpredictable re-
sults at target sites and severely decreases overall yield of
surviving cells (DiCarlo et al. 2013; Mans et al. 2015; Stovicek,
Borodina and Forster 2015). It has been shown that short single-
strand (Generoso et al. 2016) or double-strand DNA donor oli-
gos (DiCarlo et al. 2013) sharing homology with a target site can
serve as the simplest repair template. The donor oligo can be
of various lengths, ranging between 80 and 120 bp, and can in-
troduce various changes such as a premature STOP codon (Di-
Carlo et al. 2013), a heterologous disrupting sequence (Horwitz
et al. 2015), a barcode (Ryan et al. 2014) for easier genotyping
or an entire ORF deletion (Mans et al. 2015) (Fig. 1). The PAM
site should always be removed from the donor sequence to pre-
vent the cutting by Cas9 (DiCarlo et al. 2013). The repair tem-
plate can also be delivered as a part of an expression vector
(Bao et al. 2015; Garst et al. 2017). Longer gene expression cas-
settes with at least 40-bp homology to the target site can also
be used as repair templates. They enable integration of larger
DNA fragments, e.g. carrying gene expression cassettes (DiCarlo
et al. 2013; Stovicek, Borodina and Forster 2015). TheCRISPR/Cas9
approach has also been combined with in vivo assembly of sev-
eral overlapping DNA parts (Fig. 1). Ryan et al. (2014) reported
70%–85% efficiency for assembly of a gene expression cassette
consisting of three parts with 50 bp overlaps to a targeted lo-
cus in a diploid or polyploid strain. In another study, one trans-
formation event enabled integration of six overlapping gene
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expression cassettes into a single-gene locuswhile another gene
was deleted using a short oligo simultaneously (Mans et al. 2015).
A multiplex approach CasEMBLR demonstrated assembly of five
overlapping DNA parts per locus in up to three different loci si-
multaneously with an efficiency ranging between 30% and 97%
(Jakocˇiu¯nas et al. 2015b). A metabolic pathway consisting of 11
genes on six DNA parts flanked with 500 bp arms homologous
to three independent loci was used as a DSB repair template in
the gap-repair gRNA delivery approach resulting in 4% efficiency
of the pathway assembly (Horwitz et al. 2015). Tsai et al. (2015)
integrated two copies of a multigene pathway consisting of six
genes on four DNA parts with 300 bp homologous arms into two
different gene loci with 25%–100% efficiency. As the integration
of a gene expression cassette into an ORFmay influence expres-
sion of the heterologous gene (Stovicek, Borodina and Forster
2015), several toolkits targeting intergenic regions providing re-
liable level of gene expression have been developed. Three-DNA
part gene expression cassettes with 1 kbp homologous arms
used as a donor template resulted in 40%–95% integration ef-
ficiency depending on the particular site targeted (Reider Apel
et al. 2016). Although versatile, in vivo CRISPR/Cas9-mediated as-
sembly requires tedious multiplex genotyping. Thus, preassem-
bly of donor templates with sufficiently long homologous arms
might be an alternative option to omit this. Using the system de-
veloped by Bao et al. (2015), preassembled large metabolic path-
ways were integrated into transposable Ty elements in mul-
tiple copies with efficiencies more than 80% (Shi et al. 2016).
Ronda et al. (2015) targeted multiple validated intergenic loci
with preassembled gene expression cassettes reaching efficien-
cies of 84% with three simultaneous integrations. When using
the marker-free variant of previously designed integrative vec-
tors (Jensen et al. 2014; Stovicek et al. 2015) targeting intergenic
loci, integration of up to six heterologous genes was achieved
with 70% efficiency (Jessop-Fabre et al. 2016). In summary, due
to the high efficiency of HR, large pathways can be assembled
directly in vivo omitting in vitro cloning steps. However, the pre-
assembly of donor DNA fragments always leads to higher inte-
gration efficiencies and does not require subsequent extensive
genotyping.
Taken together, mainly linear DNA fragments of different
length have been successfully used for efficient DSB repair. How-
ever, a recent study demonstrated that episomal vectors that
contain both a gRNA expression cassette and a DNA repair tem-
plate could also be used in the yeast S. cerevisiae (Garst et al. 2017).
In a proof-of-concept experiment, ADE2 gene was mutated with
95% efficiency in a laboratory strain and with 70% efficiency in
a wine strain. A particular advantage of this method is that the
combined DNA elements, which contain a gRNA and a corre-
sponding repair template, are small enough (∼200 bp) to be syn-
thesized by high-throughput oligomer synthesis on arrays. Com-
bined with a high transformation efficiency of episomal vectors
into yeast, this enables generation of large strain libraries.
Direct DNA editing using CRISPR-cytidine deaminase
fusion
A method for CRISPR-based targeted DNA mutagenesis was de-
scribed by taking advantage of an activation-induced cytidine
deaminase (AID), which is normally responsible for somatic
hypermutation of the variable regions of antibodies (Nishida
et al. 2016). When AID was expressed as a fusion with dCas9
in S. cerevisiae, AID deaminated deoxycytidine to deoxyuri-
dine 15–19 bases upstream of the PAM sequence on the non-
complementary strand to gRNA, effectively creating C→G/T
point mutations. The efficiency of gene inactivation using this
approach was 16%–47%, depending on the chosen target site.
The advantage of the CRISPR-AIDmethod is a reduced toxicity in
comparison to the nuclease-based CRISPR approaches (Nishida
et al. 2016).
CRISPR/Cas9 GENOME EDITING IN DIFFERENT
YEAST SPECIES
Kluyveromyces lactis
Kluyveromyces lactis is used industrially for the production of
recombinant proteins, fermented dairy products and some
metabolites (Spohner et al. 2016). Horwitz et al. (2015) demon-
strated CRISPR/Cas9 genome editing in an industrial strain of K.
lactis. The 2μ element in the expression vector was exchanged
for the pKD1 vector-stabilizing element. To decrease the NHEJ
activity in K. lactis, the authors deleted YKU80 gene. Although
with low efficiency (2.3%), the method allowed integration of
three six-geneDNAparts into three individual chromosomal loci
(Horwitz et al. 2015).
Yarrowia lipolytica
Yarrowia lipolytica is the most studied oleaginous yeast and
is applied in the biotechnology industry for the production
of lipase, citric acid, lactone fragrances and recently also ω-3
fatty acids (Thevenieau, Nicaud and Gaillardin 2009; Xue et al.
2013). Several recent studies have demonstrated the potential
of the CRISPR/Cas9 system in this yeast. Schwartz et al. (2016a)
constructed Yarrowia codon-optimized Cas9 and hybrid SCR1´-
tRNA promoter for gRNA expression on a centromeric vector
(Schwartz et al. 2016a). It enabled efficient NHEJ-generated gene
deletions. More than 50% or 90% of the cells acquired a gene
deletion after 2 or 4-day outgrowth of the transformed cells, re-
spectively. HR-mediated gene deletions with a donor fragment
with 1-kbp homologous arms were also obtained with high effi-
ciency. The HR-mediated repair was pronounced in KU70 mu-
tant, lacking NHEJ-mediated response (Schwartz et al. 2016a).
A possibility of multiplex gene deletion in Y. lipolytica was also
demonstrated (Gao et al. 2016). Here a vector was designed to
carry Yarrowia codon-optimized Cas9 gene driven by the strong,
endogenous TEF1 promoter, and also gRNAs flanked with the
HH and HDV ribozymes expressed from the TEF1 promoter. In
the absence of donor DNA, NHEJ-mediated gene nonsense mu-
tations occurredwith efficiencies of 85%, 36% or 19% for one, two
or three targeted genes, respectively, after 4 days of outgrowth
of the transformed cells. Furthermore, HR-mediated gene dis-
ruption was shown when the donor template was delivered on
the Cas9/gRNA vector, with higher rates in KU70/80 mutants
(Gao et al. 2016). CRISPR/Cas9 also allowed the development of
a toolkit for integration of donor cassettes which were deliv-
ered into the cells by a separate replicative vector requiring an
additional selection during the transformation (Schwartz et al.
2016b). In an NHEJ-positive strain, 5 out of 17 tested locations
were targeted with integration efficiencies from 48% to 69%,
while 3 sites showed<6% and the remaining 9 sites did not show
any positive integration. Sequential markerless integration of a
metabolic pathway into the described loci was shown (Schwartz
et al. 2016b).
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Komagataella phaffii (formerly Pichia pastoris)
Komagataella phaffii (P. pastoris) is an important recombinant pro-
tein producer due to its excellent folding and secretion capabil-
ity. However, it is poor in HR, which makes it very hard to engi-
neer. Weninger et al. (2016) extensively tested different modes of
expression of the Cas9 gene and gRNA molecules. Use of a low-
copy ARS element vector with bidirectional native HXT1 pro-
moter driving the expression of human codon-optimized Cas9
andHH/HDV-ribozyme-flanked gRNA transcript resulted in up to
90% of single-gene nonsense mutations. When two genes were
targeted, nonsensemutations in bothORFswere observedwith a
frequency of 69%. Although a donor template with 1-kbp homol-
ogous arms was provided, only very low integration efficiency
(2%) occurred suggesting that NHEJ remained the dominant way
of DSB repair (Weninger et al. 2016).
Schizosaccharomyces pombe
The fission yeast Sch. pombe is an important model organism for
the study of eukaryotic cellular biology and in particularly cell
cycle regulation (Hoffman, Wood and Fantes 2015). Jacobs et al.
(2014) used rrk1 promoter for expression of gRNA molecule as it
provides a defined 5´-leader, cleaved during maturation. The 3´-
end of the gRNAmolecule was fused to the HH ribozyme, as rrk1
is a Pol II promoter resulting in polyadenylation of mature RNAs.
Expression of gRNA and Cas9 separately on two low-copy ARS-
containing vectors (or together on one vector to minimize the
observed negative influence of Cas9 expression on cell growth)
led to the 85%–98% efficiency of the target modification when
a PCR-amplified mutated allele was used as donor template
(Jacobs et al. 2014). A similar system enabled construction of a
single-gene deletion with 33% efficiency (Fernandez and Berro
2016).
Pathogenic yeasts
Targeted gene deletions are necessary for the study of gene
functions in virulence models. In the most prevalent yeast
pathogen—Candida albicans—the absence of haploid state and
frequent aneuploidy of clinical isolates makes gene deletions
very tedious. In the absence of autonomously replicating vec-
tors, CRISPR/Cas9 was implemented via integrating Cas9 con-
trolled by ENO1 promoter and gRNA expressed from SNR52 pro-
moter into C. albicans genome (Vyas, Barrasa and Fink 2015). The
Cas9 gene was codon-optimized for CTG clade yeasts. In ‘solo’
approach, gRNA expression cassette was integrated into a strain
already expressing Cas9. In the ‘duet’ approach, both expression
cassettes were integrated in a single transformation. Both ‘solo’
and ‘duet’ systems resulted in an acceptable gene deletion effi-
ciency of 60%–80% and 20%–40%, respectively. Themore efficient
‘solo’ system was then used for generation of deletions in sev-
eral genes or deletion of two homologous genes with a single
targeting gRNA molecule. Moreover, successful nonsense muta-
tions in three different loci combining the solo and duet system
for delivery of two different gRNA cassettes were documented
(Vyas, Barrasa and Fink 2015). A possibility of transient expres-
sion of linear cassettes carrying both components was shown.
A single gene was replaced with a linear marker gene cassette
reaching more than 50% efficiency, while the linear gRNA and
Cas9 cassettes were lost at the same time (Min et al. 2016).
Another pathogenic yeast Cryptococcus neoformans exhibits
a low rate of HR that hampers its manipulation and thus
functional gene analysis. Two studies have demonstrated the
CRISPR/Cas9 system capacity to generate nonsense mutations
and to stimulate HR response in different serotypes of Cr. neofor-
mans (Arras et al. 2016; Wang et al. 2016). As circular molecules
are not stable in Cr. neoformans, linear DNA vectors were used for
expression of Cas9 nuclease and gRNAs. gRNAs were expressed
from CnU6 promoter and terminated by 6T terminator (Wang
et al. 2016). Alternatively, the Cas9 gene was integrated into the
genome and a linear vector was used for expression of a gRNA
molecule flanked with HH and HDV ribozymes from a Pol II pro-
moter (Arras et al. 2016). The introduction of nonsense muta-
tions was achieved without donor DNA with efficiency above
80%. Mutated allele used as a donor template resulted in HR-
mediated allele exchange when selecting for a particular phe-
notype. Full removal of an ORF occurred with frequencies of
20%–90%when a donormarker genewas fused to the Cas9/gRNA
cassette followed by spontaneous loss of the Cas9/gRNA part
eliminating thus the persistence of the CRISPR/Cas9 system
(Wang et al. 2016). Gene deletions were obtained in different
serotypes of Cr. neoformans by using a marker cassette with ho-
mologous arms to the given ORF. Stimulation of HR led to 70%
success rate for obtaining the mutants (Arras et al. 2016).
Another pathogenic yeast with a dominant NHEJ pathway, C.
glabrata was demonstrated to be amenable to the CRISPR/Cas9-
mediated engineering (Enkler et al. 2016). Here two centromeric
vectors carrying Cas9 and gRNA expression cassette were used.
Although adoption of Saccharomyces cerevisiae system (DiCarlo
et al. 2013) for expression of a gRNA appeared to be feasible, spe-
cific C. glabrata adjustments (RNAH promoter, tRNA terminator)
led to better performance of the system (Enkler et al. 2016). Be-
sides efficient generation of indels byNHEJ, deletion of a reporter
gene using a donor marker cassette with relatively short homol-
ogous arms was achieved with increased HR rates (Enkler et al.
2016).
TRANSCRIPTIONAL REGULATION VIA CRISPR
Targeted regulation of gene expression is important both in the
context of metabolic engineering and functional genomics. The
CRISPRmethod has been adapted both for activation and repres-
sion of gene transcription in Saccharomyces cerevisiae, but so far
not in other yeast species.
Qi et al. (2013) generated an enzymatically inactive variant
of Cas9 by mutation of both nuclease sites (D10A and H840A)
and showed that this null-nuclease dCas9 when targeted to a
coding region of a gene caused transcriptional repression in
Escherichia coli. In this approach, termed CRISPR interference
(CRISPRi), dCas9 sterically blocks the binding and action of RNA
polymerase. In a follow-up study, dCas9 was guided to a pro-
moter region, resulting in efficient gene repression in S. cerevisiae
(Gilbert et al. 2013). The repression could be further enhanced
by fusing a repressor domain to dCas9 (Fig. 3). GFP fluorescence
was reduced 18-foldwhen the TEF1 promoter driving the GFP ex-
pression was targeted by dCas9, and the fluorescence decreased
53-fold when the same region was targeted by dCas9 fused to a
mammalian transcriptional repressor domainMxi1 (Gilbert et al.
2013).
Farzadfard, Perli and Lu (2013) fused dCas9 to an activator do-
main (VP64) instead. The resulting chimeric protein could both
repress and activate gene expression depending on the target-
ing site in the promoter region. When dCas9-VP64 was targeted
to the region upstream the TATA box of the minimal CYC1m
promoter, the promoter was activated. Targeting the sites im-
mediately adjacent to the TATA box or transcriptional start site
12 FEMS Yeast Research, 2017, Vol. 17, No. 5
Figure 3. Overview of transcriptional control via CRISPR/Cas9 in yeast. (A) Steric
block of transcriptional initiation/elongation by catalytically inactive (‘dead’)
dCas9 bound in the promoter region. (B) Transcriptional activation/repression
using dCas9 fused to transcriptional activator/repressor domains. (C) Multi-
ple transcriptional regulation action using effector proteins recruited by RNA
scaffolds. Pol III—RNA Polymerase III, NLS—nucleolar localization sequence,
L—self-cleaved leader sequence (e.g. SNR52), cr—crRNA, tracr—tracrRNA, TF—
transcription factor, scRNA—scaffold RNA, Linker—scaffold RNA-binding linker
protein domain.
repressed the expression from PCYC1m. The obtained activation
level was not very high, max 2.5-fold. To achieve a higher level
of activation, the authors created a synthetic promoter by array-
ing multiple operators upstream the PCYC1m. The activation level
increased proportionally to the number of operators, reaching
70-fold activation for 12 operators (Farzadfard, Perli and Lu 2013).
Fusion of dCas9 to a tripartite activator (VPR) composed of
three strong activation domains (VP64, p65 and Rta) resulted in
38 and 78-fold activation of promoters PHED1 and PGAL7, respec-
tively. Fusion of dCas9 with VP64 only gave 9 and 14-fold activa-
tion of the same promoters (Chavez et al. 2015).
Zalatan et al. (2015) undertook a different approach to achieve
targeted upregulation and downregulation. Instead of fusing ac-
tivation or repression domains to dCas9, they included effec-
tor protein recruitment domains into the guide RNA (Fig. 3).
In the same strain, they expressed dCas9 and regulation pro-
teins, fused with RNA-binding domains. They termed the re-
sulting gRNAs with protein recruitment capabilities ‘scaffold
RNA’ (scRNA). Gene activation using scRNA binding VP64 acti-
vation domain was 20 to 50-fold, much higher than the activa-
tion achieved with dCas9-VP64 fusion. Several hairpins could be
combined in a single scRNA, which allowed amplification of ac-
tivation or combination of repression and activation of different
sites (Zalatan et al. 2015).
In addition to the studies mentioned above focusing on the
on/off states of gene expression, grade modulation of gene ex-
pression using dCas9 fused to either an activation or repression
domain was shown (Deaner and Alper 2017). This was achieved
by changing the gRNA target location and thus recruiting the
dCas9-activator/repressor complex to different positions in gene
promoters. It resulted in a dynamic range of gene expression
from almost silenced gene to its several 10-fold overexpression
related to the proximity of the dCas9-based regulators to the
core of the promoter. The graded gene expression enabled tun-
ing of metabolic pathways and optimization of the desired phe-
notypes in several metabolic engineering applications (Deaner
and Alper 2017).
APPLICATION OF CRISPR/Cas9 FOR
ENGINEERING OF YEAST CELL FACTORIES
CRISPR/Cas genome editing and transcriptional regulation are
particularly suitable for developing yeast cell factories. As the
strain development usually proceeds through iterative design-
build-test cycles, the CRISPR technology facilitates this process
because the strains can repeatedly be edited in a flexible mul-
tiplex way. As far as transcriptional regulation is concerned,
CRISPR also enables relatively easy multiplexing. We will illus-
trate this with four brief examples (Fig. 4).
Shi et al. (2016) applied CRISPR/Cas9 to engineer Saccharo-
myces cerevisiae towards production of a non-native product
(R,R)-2,3-butanediol (BDO) from a non-native substrate xylose in
a single transformation step. A 24-kb integration construct con-
sisting of six gene expression cassettes (three for the xylose con-
sumption pathway and three for the BDO biosynthesis pathway)
was integrated into the delta sequence of the Ty transposon el-
ements. Introducing Cas9-mediated DSBs at the delta sites al-
lowed the integration of 10 copies of the 24-kb DNA fragment. A
higher copy number of the pathways resulted in both higher xy-
lose consumption rate and higher BDO production, where 0.31
g/L of BDO was produced from 20 g/L xylose (Shi et al. 2016).
Stovicek et al. (2015) engineered diploid industrial S. cerevisiae
strain Ethanol Red, used inmany first generation ethanol plants,
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Figure 4. Application of CRISPR/Cas9 systems for engineering of yeast cell factories. (A) Production of (R,R)-2,3-butanediol from xylose. Multicopy one-step integration
of the xylose utilization and (R,R)-2,3-butanediol pathways into Ty-element delta sites in the genome (The figure is reprinted with permission from Elsevier: Shi et al. A
highly efficient single-step,markerless strategy formulticopy chromosomal integration of large biochemical pathways in Saccharomyces cerevisiae.Metab Eng 2016;33:19–
27.). (B) Production of lactic acid from glucose in an industrial yeast strain, one-step disruption of two genes in diploid strain and simultaneous integration of lactate
dehydrogenase genes from L. plantarum (ldhL) (Stovicek, Borodina and Forster 2015). (C) Production of deoxyviolacein, violacein, prodeoxyviolacein and proviolacein
from glucose. Transcriptional regulation (activation/repression) of different genes in violacein pathway leads to production of different violacein derivatives (The
figure is reprinted with permission from Elsevier: Zalatan et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds. Cell 2015;160:339–
50.): VP64-activator domain, PP7/MS2 – RNA hairpin structures, PCP/MCP—RNA binding proteins. (D) Production of naringenin from glucose. Cas9-mediated one-step
integration of the naringenin pathway into an intergenic locus. Downregulation of TSC13 mediated by catalytically inactive (‘dead’) dCas9 (CRISPRi) to avoid the
formation of by-products (The figure adapted from Vanegas, Lehka and Mortensen 2017).
to produce lactic acid by replacing both alleles of pyruvate decar-
boxylase genes PDC1 and PDC5with L-lactate dehydrogenase en-
coding gene (ldhL) from Lactobacillus plantarum. The geneticmod-
ification was accomplished in a single transformation event,
leading to a strain producing 2.5 g/L lactic acid with the yield of
0.49 g of lactic acid/g of glucose (Stovicek, Borodina and Forster
2015).
Transcriptional regulation via CRISPRi was demonstrated for
the production of the bacterial pigment violacein in S. cerevisiae.
Here CRISPR RNA scaffolds were used to recruit transcriptional
activators and repressors, alone or simultaneously, to a pro-
moter site, which allowed tight control of transcriptional activa-
tion and repression. By simply changing the RNA scaffolds, the
same strain could be reprogrammed to produce different ratios
of the pathway products, deoxyviolacein, violacein, prodeoxyvi-
olacein and proviolacein. Combining these RNA-encoded cir-
cuits with conditional expression of Cas9, a system for switch-
ing from growth to production phase was obtained (Zalatan et al.
2015).
Recently, a combination of Cas9 genome editing and dCas9
transcriptional regulation was demonstrated by engineering S.
cerevisiae for production of flavonoid precursor naringenin. First,
Cas9 was used for integration of a multigene pathway into
an intergenic locus leading to production of naringenin from
phenylalanine. Next, the naringenin production was increased
through dCas9-mediated downregulation of an essential gene
TSC13 to prevent the formation of by-product phloretic acid
(Vanegas, Lehka and Mortensen 2017).
OUTLOOK
This review summarizes the recent developments of CRISPR-
based systems for genome editing and transcriptional regu-
lation in various yeast species. The CRISPR/Cas9 technology
has advantages over conventional marker-based genome edit-
ing in several aspects. It enables fast strain engineering of pro-
totrophic wild and industrial yeast strains. Furthermore, it al-
lows performing multiple genome edits simultaneously and is
independent of marker cassette integration. For transcriptional
regulation, the CRISPR offers an advantage of relatively easy
design and implementation, the possibility of multiplexing
and orthogonality. However, to enable the wide adaptation
of CRISPR, the current limitations need to be addressed.
These include (i) design of efficient and specific targeting for
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different yeast species, (ii) elimination of cloning necessity, (iii)
enabling large-scale multiplexing and, finally, (iv) resolving the
IP issues. The uncertainty about the ownership of the CRISPR
technology delays its adaptation for industrial biotechnology
and pharmaceutical applications and must be resolved as soon
as possible so the technology can unfold its true potential.
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